| Net Cash Provided by (Used in) Operating Activities |
$74,918 |
USD |
-4.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$230,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$8,434 |
USD |
49% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
211,101,313 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$504 |
USD |
-94% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$597,545 |
USD |
36% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$3,670 |
USD |
-16% |
Q2 2025 |
Q2 2025 |
| Property, Plant and Equipment, Gross |
$94,751 |
USD |
-34% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
576,562 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$58,809 |
USD |
-97% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
576,562 |
shares |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$61,009 |
USD |
46% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |